Letter to CMS on Open Payments Program
December 3, 2018 | The Endocrine Society joined other national and state physician organizations in a letter responding to CMS' request for feedback on their reporting requirements under the Open Payments Program. The Society believes that CMS' decision to require reporting of medical textbooks and journal reprints make it difficult for physicians to stay abreast of the latest advances in medical care.
Comments on BRAIN 2025: A Scientific Vision
November 15, 2018 | In our comments, we highlight important information about the role of hormones in understanding the structure and function of the brain and encourage the BRAIN Initiative working group to prioritize endocrinology in research areas supported by the Scientific Vision.
DAA Comments on National Clinical Care Commission
October 23, 2018 | The Diabetes Advocacy Alliance provides comments supporting the establishment of the National Clinical Care Commission and advocating for increased access to the Medicare Diabetes Prevention Program, diabetes self-management training services, and screening for Type 2 Diabetes.
DAA Sign-on Addressing Blood Glucose Monitoring Accuracy
October 23, 2018 | The Diabetes Advocacy Alliance urges the Department of Health and Human Services and the U.S. Food and Drug Administration to address blood glucose system accuracy to ensure for people with diabetes have access to safe diabetes technologies.
Title VII Pediatric Subspecialty Loan Repayment Sign-On
October 9, 2018 | The Endocrine Society joined over 60 other organizations on a letter calling on the Senate to include an authorization level for the Pediatric Subspecialty Loan Repayment program in the Title VII workforce bill.
Representing the Endocrine Society, our members strive to influence public policy related to research and clinical endocrinology issues by testifying before the United States Congress, Federal agencies, and other legislative and deliberative bodies.